|1.||Bondarenko, A L: 1 article (04/2009)|
|2.||Strazhnikova, G A: 1 article (04/2009)|
|3.||Ustiuzhaninov, V N: 1 article (04/2009)|
|4.||Vozhegova, N P: 1 article (04/2009)|
05/01/1992 - "After correction for the number of examined antigens a significantly higher prevalence was proved only in HLA-B21 in patients with the obstructive form and in patients with advanced myocardial hypertrophy (thickness of more than 30 mm). "
01/01/1991 - "However, after correction for the number of antigens tested, only HLA-B21 was shown to have a significantly high frequency (in patients with the obstructive form and in those with advanced myocardial hypertrophy, defined as a wall thickness greater than 30 mm). "
|2.||Heart Diseases (Heart Disease)
01/01/1999 - "We found a lower frequency than expected of HLA B21 (10.44 expected, none observed) among patients with ischaemic heart disease but no other significant differences. "
01/01/1991 - "In Czechoslovakia, HLA-B21 carriers are at increased risk of developing a serious heart disease manifesting already in young age."